Literature DB >> 20610576

Informed consent to research in persons with schizophrenia spectrum disorders.

Lora Humphrey Beebe1, Kathlene Smith.   

Abstract

This manuscript describes the responses and correlates of outpatients with schizophrenia spectrum disorders to a tool designed to measure comprehension before obtaining informed consent for research participation. We used the Evaluation to Sign Consent form to document comprehension in 100 outpatients as part of their consent to participate in an ongoing study of an exercise intervention. The findings suggest that using this form is a feasible and acceptable approach to documenting comprehension of research procedures prior to obtaining informed consent. Age 49 years and older and the receipt of intramuscular antipsychotic medication predicted the need for additional assistance to complete the Evaluation to Sign Consent form successfully (chi(2) = 8.29, P = 0.016). Nurse researchers should consider documenting comprehension with this tool owing to its availability, time efficiency and utility.

Entities:  

Mesh:

Year:  2010        PMID: 20610576      PMCID: PMC2947338          DOI: 10.1177/0969733010364581

Source DB:  PubMed          Journal:  Nurs Ethics        ISSN: 0969-7330            Impact factor:   2.874


  20 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Decisional capacity for informed consent in schizophrenia research.

Authors:  W T Carpenter; J M Gold; A C Lahti; C A Queern; R R Conley; J J Bartko; J Kovnick; P S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2000-06

3.  Another view of therapy for cognition in schizophrenia.

Authors:  William T Carpenter; James M Gold
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

4.  Assessment of capacity to give consent to research participation: state-of-the-art and beyond.

Authors:  E G DeRenzo; R R Conley; R Love
Journal:  J Health Care Law Policy       Date:  1998

5.  Can the client with chronic schizophrenia consent to nursing research?

Authors:  R Davidhizar; D Wehlage
Journal:  J Adv Nurs       Date:  1984-07       Impact factor: 3.187

6.  Does cognitive function improve with quetiapine in comparison to haloperidol?

Authors:  Dawn I Velligan; John Newcomer; Joseph Pultz; John Csernansky; Anne L Hoff; Roderick Mahurin; Alexander L Miller
Journal:  Schizophr Res       Date:  2002-01-15       Impact factor: 4.939

7.  A preliminary study of interactive questioning methods to assess and improve understanding of informed consent among patients with schizophrenia.

Authors:  Lisa T Eyler; Heline Mirzakhanian; Dilip V Jeste
Journal:  Schizophr Res       Date:  2005-06-15       Impact factor: 4.939

8.  Capacity to provide informed consent for participation in schizophrenia and HIV research.

Authors:  David J Moser; Susan K Schultz; Stephan Arndt; Michelle L Benjamin; Frank W Fleming; Colleen S Brems; Jane S Paulsen; Paul S Appelbaum; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

9.  TIPS: telephone intervention--problem solving for persons with schizophrenia.

Authors:  Lora Humphrey Beebe; Lili Tian
Journal:  Issues Ment Health Nurs       Date:  2004 Apr-May       Impact factor: 1.835

10.  Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.

Authors:  Dilip V Jeste; Barton W Palmer; Shahrokh Golshan; Lisa T Eyler; Laura B Dunn; Thomas Meeks; Danielle Glorioso; Ian Fellows; Helena Kraemer; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

View more
  1 in total

Review 1.  Psychopharmacology of aggression in schizophrenia.

Authors:  Peter Buckley; Leslie Citrome; Carmen Nichita; Michael Vitacco
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.